Literature DB >> 17960454

Benefit of ultrasonography in the detection of clinically and mammographically occult breast cancer.

Sharon W W Chan1, Polly S Y Cheung, Stefanie Chan, Suk Sze Lau, Ting Ting Wong, Michael Ma, Ada Wong, Yuen Ching Law.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the performance of high-resolution ultrasonography in the detection of clinically and mammographically occult breast cancer.
MATERIALS AND METHODS: From September 2003 to November 2006, a total of 1485 patients were confirmed to have in situ or invasive breast cancer in Hong Kong Sanatorium and Hospital Breast Care Centre. All patients underwent mammography (MMG) and/ or sonography (USG) evaluation. Patients' age and size of tumor detected by USG alone were compared with those detected by MMG.
RESULTS: Altogether, 222 patients (17%) had positive imaging findings on USG only, among which 22 (13%) patients had nonpalpable tumors. Performing USG increased the cancer detection rate among clinically and mammographically occult breast lesions by 14.3%. The mean size of the tumors detected only by USG was 1.98 cm, which was not significantly different from the mean size of tumor detected by MMG (1.46) (p = 0.23). This remains true in the group of patients with nonpalpable tumors (1.36 vs. 1.46 cm, p = 0.88). The sensitivity of USG is 91%, which is significantly higher than that of MMG (78%) (p = 0.001). This remains true in patients age <40 or > or = 40, tumor grading I toIII, and LVI +/- cases. However, MMG had higher sensitivity in the group of patients with nonpalpable tumors (73% vs. 62%, p = 0.01) and noninvasive cancers (72% vs. 69%, p = 0.01).
CONCLUSIONS: The use of high-resolution USG may lead to detection of a significant number of occult cancers that are no different in size from nonpalpable mammographically detected lesions.

Entities:  

Mesh:

Year:  2008        PMID: 17960454     DOI: 10.1007/s00268-007-9273-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

Review 1.  Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666.

Authors:  Wendie A Berg
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

2.  Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue.

Authors:  S S Kaplan
Journal:  Radiology       Date:  2001-12       Impact factor: 11.105

3.  Whole-breast US imaging: four-year follow-up.

Authors:  D B Kopans; J E Meyer; K K Lindfors
Journal:  Radiology       Date:  1985-11       Impact factor: 11.105

4.  Malignant breast masses detected only by ultrasound. A retrospective review.

Authors:  P B Gordon; S L Goldenberg
Journal:  Cancer       Date:  1995-08-15       Impact factor: 6.860

5.  Ultrasound analysis of 104 primary breast carcinomas classified according to histopathologic type.

Authors:  C Cole-Beuglet; R Z Soriano; A B Kurtz; B B Goldberg
Journal:  Radiology       Date:  1983-04       Impact factor: 11.105

6.  Occult cancer in women with dense breasts: detection with screening US--diagnostic yield and tumor characteristics.

Authors:  T M Kolb; J Lichy; J H Newhouse
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

7.  Incidental findings on sonography of the breast: clinical significance and diagnostic workup.

Authors:  W Buchberger; P DeKoekkoek-Doll; P Springer; P Obrist; M Dünser
Journal:  AJR Am J Roentgenol       Date:  1999-10       Impact factor: 3.959

8.  Automated and hand-held breast US: effect on patient management.

Authors:  L W Bassett; C Kimme-Smith; L K Sutherland; R H Gold; D Sarti; W King
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

9.  Using sonography to screen women with mammographically dense breasts.

Authors:  Pavel Crystal; Selwyn D Strano; Semyon Shcharynski; Michael J Koretz
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

Review 10.  Evaluation of a palpable breast mass.

Authors:  W L Donegan
Journal:  N Engl J Med       Date:  1992-09-24       Impact factor: 91.245

View more
  6 in total

1.  Value of the correct diagnostic pathway through conventional imaging (mammography and ultrasound) in evaluating breast disease.

Authors:  C A Pistolese; T Perretta; E Cossu; F Della Gatta; S Giura; G Simonetti
Journal:  Radiol Med       Date:  2011-06       Impact factor: 3.469

2.  Comparison between fine needle aspiration cytology (FNAC) and core needle biopsy (CNB) in the diagnosis of breast lesions.

Authors:  M Moschetta; M Telegrafo; D A Carluccio; J P Jablonska; L Rella; Gabriella Serio; M Carrozzo; A A Stabile Ianora; G Angelelli
Journal:  G Chir       Date:  2014 Jul-Aug

3.  The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes.

Authors:  Tsun-Hou Chang; Hsian-He Hsu; Yu-Ching Chou; Jyh-Cherng Yu; Giu-Cheng Hsu; Guo-Shu Huang; Guo-Shiou Liao
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

4.  Survival outcomes of different treatment methods for the ipsilateral breast of occult breast cancer patients with axillary lymph node metastasis: a single center experience.

Authors:  Sang Min Woo; Byung Ho Son; Jong Won Lee; Hee Jeong Kim; Jong Han Yu; Beom Seok Ko; Guiyun Sohn; Yu Ra Lee; Hanna Kim; Sei Hyun Ahn; Seung Hee Baek
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

5.  The contribution of three-dimensional power Doppler imaging in the preoperative assessment of breast tumors: a preliminary report.

Authors:  K Kalmantis; C Dimitrakakis; Ch Koumpis; A Tsigginou; N Papantoniou; S Mesogitis; A Antsaklis
Journal:  Obstet Gynecol Int       Date:  2009

6.  A Low-Cost, Low-Skill Model for Efficient Breast Cancer Screening in Low Resource Rural Settings of a Developing Country.

Authors:  Sachin Khanduri; Mriganki Chaudhary; Tushar Sabharwal; Tarim Usmani; Aakshit Goyal; Shobha Khanduri; Saurav Bhagat; Fahimul Huda; Santosh Yadav; Gaurav Katyal
Journal:  Cureus       Date:  2017-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.